Demo Sign up Log In

Xeris Biopharma Holdings Inc (XERS)

Cash Conversion Ratio

-0.26×

Quarterly · Period ending: Jun 30, 2026

XERS Cash Conversion Ratio

Latest reported-0.26×period endingJun 30, 2026

Latest reported-0.26×period endingJun 30, 2026

XERS Quarterly Cash Conversion Ratio (0.83× → -0.26×)

Latest values, visible window

High-resolution chart · PNG

XERS cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	-0.259×
Mar 31, 2026	4.2726×
Dec 31, 2025	1.7787×
Sep 30, 2025	29.0966×
Jun 30, 2025	0.0503×
Mar 31, 2025	1.0894×
Dec 31, 2024	-0.3432×
Sep 30, 2024	0.5332×
Jun 30, 2024	0.7161×
Mar 31, 2024	1.0783×
Dec 31, 2023	-0.4596×
Sep 30, 2023	1.2269×
Jun 30, 2023	0.7707×
Mar 31, 2023	1.5669×
Dec 31, 2022	1.2568×
Sep 30, 2022	0.8213×
Jun 30, 2022	0.7953×
Mar 31, 2022	1.4359×
Dec 31, 2021	0.5725×
Sep 30, 2021	0.8812×
Jun 30, 2021	0.7356×
Mar 31, 2021	1.3245×
Dec 31, 2020	0.5076×
Sep 30, 2020	1.0603×
Jun 30, 2020	0.9919×
Mar 31, 2020	0.9927×
Dec 31, 2019	0.9013×
Sep 30, 2019	0.9426×
Jun 30, 2019	0.6785×
Mar 31, 2019	0.8448×
Dec 31, 2018	0.9102×
Sep 30, 2018	1.1301×
Jun 30, 2018	1.1071×
Mar 31, 2018	0.6835×
Dec 31, 2017	1.0208×
Sep 30, 2017	0.7443×
Jun 30, 2017	1.2546×
Mar 31, 2017	0.8305×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.